|
Volumn 30, Issue 4, 2009, Pages 335-339
|
New antiepileptic drugs;Les nouveaux antiépileptiques
|
Author keywords
Epilepsy; Treatment
|
Indexed keywords
ALCOHOL;
ANTICONVULSIVE AGENT;
CARBAMAZEPINE;
ETIRACETAM;
GABAPENTIN;
LAMOTRIGINE;
LORAZEPAM;
MONOAMINE OXIDASE INHIBITOR;
OXCARBAZEPINE;
PHENOBARBITAL;
PHENYTOIN;
PREGABALIN;
TOPIRAMATE;
VALPROIC ACID;
ZONISAMIDE;
ADD ON THERAPY;
ANOREXIA;
ASTHENIA;
ATAXIA;
COMPLEX PARTIAL SEIZURE;
CONFUSION;
CONJUNCTIVITIS;
DIPLOPIA;
DISEASE EXACERBATION;
DRUG ACTIVITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG FEVER;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG USE;
EDEMA;
EPILEPSY;
FOCAL EPILEPSY;
GENERALIZED EPILEPSY;
HUMAN;
HYPONATREMIA;
IRRITABILITY;
MONOTHERAPY;
NEPHROLITHIASIS;
PATHOPHYSIOLOGY;
QUALITY OF LIFE;
RECOMMENDED DRUG DOSE;
SHORT SURVEY;
SIDE EFFECT;
SOMNOLENCE;
TREATMENT INDICATION;
UROLITHIASIS;
VERTIGO;
AMINES;
ANTICONVULSANTS;
CARBAMAZEPINE;
CYCLOHEXANECARBOXYLIC ACIDS;
EPILEPSIES, PARTIAL;
EPILEPSY;
GAMMA-AMINOBUTYRIC ACID;
HUMANS;
ISOXAZOLES;
PIRACETAM;
TRIAZINES;
|
EID: 63049109465
PISSN: 02488663
EISSN: 17683122
Source Type: Journal
DOI: 10.1016/j.revmed.2008.11.009 Document Type: Short Survey |
Times cited : (2)
|
References (7)
|